Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Debt Ratio: 2013-2025

Historic Debt Ratio for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Sep 2025 value amounting to 0.37.

  • Amphastar Pharmaceuticals' Debt Ratio fell 5.27% to 0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37, marking a year-over-year decrease of 5.27%. This contributed to the annual value of 0.38 for FY2024, which is 2.17% down from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Debt Ratio of 0.37 as of Q3 2025, which was down 2.92% from 0.38 recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Debt Ratio registered a high of 0.41 during Q3 2023, and its lowest value of 0.06 during Q2 2021.
  • Over the past 3 years, Amphastar Pharmaceuticals' median Debt Ratio value was 0.38 (recorded in 2024), while the average stood at 0.36.
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Debt Ratio fell by 25.62% in 2021, and later surged by 296.95% in 2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Debt Ratio (Quarterly) stood at 0.11 in 2021, then dropped by 10.78% to 0.10 in 2022, then skyrocketed by 281.32% to 0.39 in 2023, then dropped by 2.17% to 0.38 in 2024, then declined by 5.27% to 0.37 in 2025.
  • Its last three reported values are 0.37 in Q3 2025, 0.38 for Q2 2025, and 0.37 during Q1 2025.